Home > News > BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) Is The Most Active On NASDAQ During Morning Trading Hours
August 13th, 2009
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) Is The Most Active On NASDAQ During Morning Trading Hours
Abstract:
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) is currently the top mover in the morning trade session. The stock is trading at $2.36, rallied 32.59% on very unusual volume of 1.40 million shares after the company said its lead candidate LibiGel to treat female sexual dysfunction was safe in the late-stage cardiovascular and breast cancer safety study.
Source:
transworldnews.com
Related Links |
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Nanobiotechnology
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||